Optiver Holding
MRVI icon

Optiver Holding’s Maravai LifeSciences MRVI Stock Holding History

Optiver Holding’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$524 Sell
84
-704
-89% -$3.04K ﹤0.01% 2568
2026
Q1 		$2.23K Buy
788
+208
+36% +$705 ﹤0.01% 1798
2025
Q4 		$1.89K Sell
580
-1,278
-69% -$4.3K ﹤0.01% 2047
2025
Q3 		$5.33K Buy
+1,858
New +$4.74K ﹤0.01% 1695

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Optiver Holding's MRVI Position: Q2 2026 in Review

Optiver Holding reduced its Maravai LifeSciences (MRVI) stake by 89% in Q2 2026, selling an estimated $3.04K and leaving 84 shares worth $524. The position accounts for ﹤0.01% of the portfolio, ranked #2568.

Optiver Holding first reported a position in MRVI in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.33K in Q3 2025. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Optiver Holding held 84 shares of Maravai LifeSciences worth $524 as of Q2 2026.
  • Optiver Holding sold 704 Maravai LifeSciences shares in Q2 2026, an estimated $3.04K.
  • Maravai LifeSciences made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2568 holding.
  • Optiver Holding first reported a position in Maravai LifeSciences in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Maravai LifeSciences position peaked at $5.33K in Q3 2025.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.